Literature DB >> 1531620

Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone.

C J Joyner1, J M Quinn, J T Triffitt, M E Owen, N A Athanasou.   

Abstract

Studies were carried out on 3 giant cell tumours of bone (GCTB) to characterise further the cells forming the distinctive mononuclear and multinucleated components. Samples of tumours were grown as explants in vitro and implanted subcutaneously in athymic mice. Cells were characterised in terms of their cell morphology and cytochemical, antigenic and functional phenotype. In culture, giant cells formed a non-proliferative, relatively homogeneous population of cells which expressed features characteristic of the osteoclast phenotype. The mononuclear cell component was heterogeneous and included macrophage-like cells, which persisted for a short time in culture, and fibroblast-like cells which proliferated. In subcutaneous implants, the fibroblast-like cells formed a tissue which included areas of bone formation associated with regions of alkaline phosphatase activity. These observations are consistent with earlier suggestions that the neoplastic component in GCTB consists of a mononuclear stromal cell which elicits a macrophage/osteoclast response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531620     DOI: 10.1016/0169-6009(92)90820-4

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  14 in total

1.  Does lactoferrin behave as an immunohistochemical oncofetal marker in bone and cartilage human neoplasms?

Authors:  Antonio Ieni; Valeria Barresi; Maddalena Grosso; Giuseppe Speciale; Michele A Rosa; Giovanni Tuccari
Journal:  Pathol Oncol Res       Date:  2010-10-24       Impact factor: 3.201

2.  Histogenetic characterization of giant cell tumor of bone.

Authors:  Manuela Salerno; Sofia Avnet; Marco Alberghini; Armando Giunti; Nicola Baldini
Journal:  Clin Orthop Relat Res       Date:  2008-06-10       Impact factor: 4.176

3.  Giant cells in pigmented villo nodular synovitis express an osteoclast phenotype.

Authors:  S D Neale; R Kristelly; R Gundle; J M Quinn; N A Athanasou
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

4.  Association of HLA-DRB1 alleles with giant cell tumour of bone.

Authors:  S S Varanasi; N A Athanasou; I Briceno; S S Papiha; H K Datta
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

5.  Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.

Authors:  Teresa Morgan; Gerald J Atkins; Melanie K Trivett; Sandra A Johnson; Maya Kansara; Stephen L Schlicht; John L Slavin; Paul Simmons; Ian Dickinson; Gerald Powell; Peter F M Choong; Andrew J Holloway; David M Thomas
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

6.  Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.

Authors:  M J Oursler; L Pederson; L Fitzpatrick; B L Riggs; T Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4.

Authors:  Helen J Knowles; Anne-Marie Cleton-Jansen; Eberhard Korsching; Nicholas A Athanasou
Journal:  FASEB J       Date:  2010-07-28       Impact factor: 5.191

Review 8.  RANKL/RANK/OPG: key therapeutic target in bone oncology.

Authors:  Kosei Ando; Kanji Mori; Francoise Rédini; Dominique Heymann
Journal:  Curr Drug Discov Technol       Date:  2008-09

9.  Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.

Authors:  M H Zheng; Y Fan; S J Wysocki; A T Lau; T Robertson; M Beilharz; D J Wood; J M Papadimitriou
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

10.  Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.

Authors:  A H Gorn; S M Rudolph; M R Flannery; C C Morton; S Weremowicz; T Z Wang; S M Krane; S R Goldring
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.